| Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus-Unrelated Head and Neck Cancer: A Multicenter, Phase 2 Trial clinical cancer research, 2020 | 215 | 2020 |
| Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers L Zhou, T Mudianto, X Ma, R Riley, R Uppaluri clinical cancer research, 2019 | 174 | 2019 |
| The long noncoding RNA MIR210HG promotes tumor metastasis by acting as a ceRNA of miR-1226-3p to regulate mucin-1c expression in invasive breast cancer XL Xiao-yu Li1, Li-ye Zhou2, Hao Luo1, Qi Zhu1, Liang Zuo1, Gu-yue Liu1, Chu ... Aging 11, 2019 | 70 | 2019 |
| TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response Z Zeng, CJ Wong, L Yang, N Ouardaoui, D Li, W Zhang, S Gu, Y Zhang, ... Nucleic acids research 50 (D1), D1391-D1397, 2022 | 51 | 2022 |
| Acute suppression of insulin resistance-associated hepatic miR-29 in vivo improves glycemic control in adult mice. PS Yu-Han Hung, Matt Kanke, C. Lisa Kurtz, Rebecca Cubitt, Rodica P Bunaciu ... physiological genomics, 2019 | 42 | 2019 |
| Sophorolipid biosynthesis and production from diverse hydrophilic and hydrophobic carbon substrates X Ma, L Meng, H Zhang, L Zhou, J Yue, H Zhu, R Yao Applied microbiology and biotechnology 104, 77-100, 2020 | 41 | 2020 |
| Personalized cancer vaccination in head and neck cancer H Shibata, L Zhou, N Xu, AM Egloff, R Uppaluri Cancer Science 112 (3), 978-988, 2021 | 38 | 2021 |
| Cancer immunogenomic approach to neoantigen discovery in a checkpoint blockade responsive murine model of oral cavity squamous cell carcinoma P Zolkind, D Przybylski, N Marjanovic, L Nguyen, T Lin, T Johanns, ... Oncotarget 9 (3), 4109, 2018 | 34 | 2018 |
| Human microRNA-548p decreases hepatic apolipoprotein B secretion and lipid synthesis L Zhou, MM Hussain Arteriosclerosis, thrombosis, and vascular biology 37 (5), 786-793, 2017 | 28 | 2017 |
| MicroRNAs regulating apolipoprotein B-containing lipoprotein production L Zhou, S Irani, A Sirwi, MM Hussain Biochimica et Biophysica Acta (BBA)-molecular and cell biology of lipids …, 2016 | 26 | 2016 |
| Epigenetic modulation of immunotherapy and implications in head and neck cancer Liye Zhou, Na Xu, Hirofumi Shibata, Vassiliki Saloura & Ravindra Uppaluri Cancer and Metastasis Reviews, 2021 | 25 | 2021 |
| Checkpoint blockade-induced CD8+ T cell differentiation in head and neck cancer responders L Zhou, Z Zeng, AM Egloff, F Zhang, F Guo, KM Campbell, P Du, J Fu, ... Journal for immunotherapy of cancer 10 (1), 2022 | 20 | 2022 |
| Regulating intestinal function to reduce atherogenic lipoproteins MM Hussain, TM Leung, L Zhou, S Abu-Merhi Clinical lipidology 8 (4), 481-490, 2013 | 18 | 2013 |
| MiR-29 Regulates de novo Lipogenesis in the Liver and Circulating Triglyceride Levels in a Sirt1-Dependent Manner YH Hung, M Kanke, CL Kurtz, RL Cubitt, RP Bunaciu, L Zhou, PJ White, ... Frontiers in Physiology 10, 1367, 2019 | 16 | 2019 |
| Autophagy plays a critical role in insulin resistance-mediated chemoresistance in hepatocellular carcinoma cells by regulating the ER stress L Li, X Liu, L Zhou, W Wang, Z Liu, Y Cheng, J Li, H Wei Journal of Cancer 9 (23), 4314, 2018 | 16 | 2018 |
| Preexisting tumor-resident T cells with cytotoxic potential associate with response to neoadjuvant anti–PD-1 in head and neck cancer G Oliveira, AM Egloff, AB Afeyan, JO Wolff, Z Zeng, RD Chernock, L Zhou, ... Science immunology 8 (87), eadf4968, 2023 | 15 | 2023 |
| Integrating CD4+ T cell help for therapeutic cancer vaccination in a preclinical head and neck cancer model H Shibata, N Xu, S Saito, L Zhou, I Ozgenc, J Webb, C Fu, P Zolkind, ... Oncoimmunology 10 (1), 1958589, 2021 | 11 | 2021 |
| Nitrated apolipoprotein AI/apolipoprotein AI ratio is increased in diabetic patients with coronary artery disease X Chen, A Bakillah, L Zhou, X Pan, F Hoepfner, M Jacob, XC Jiang, ... Atherosclerosis 245, 12-21, 2016 | 10 | 2016 |
| Lipids and dyslipoproteinemia X Chen, L Zhou, MM Hussain Henry's Clinical Diagnosis and Management by Laboratory Methods: First South …, 2016 | 9 | 2016 |
| Correction: Neoadjuvant and Adjuvant Pembrolizumab in Resectable Locally Advanced, Human Papillomavirus–unrelated Head and Neck Cancer: A Multicenter, Phase II Trial R Uppaluri, KM Campbell, AM Egloff, P Zolkind, ZL Skidmore, ... Clinical Cancer Research 27 (1), 357-357, 2021 | 6 | 2021 |
